BioPharma Dive ٢٣ فبراير ٢٠٢٦ Novo’s next-gen obesity shot fails to match Lilly drug in head-to-head study
BioPharma Dive ١٩ فبراير ٢٠٢٦ Altesa, run by former Trump official, raises $75M for well-traveled lung drug
BioPharma Dive ١٩ فبراير ٢٠٢٦ FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals
BioPharma Dive ١٨ فبراير ٢٠٢٦ FDA accepts BMS protein degrader for review; Disc rare disease drug rejected